Former biotech analyst Jason Napodano sentenced to a short stretch in a federal prison for securities fraud
Former biotech analyst Jason Napodano will be spending this fall in a federal penitentiary.
After settling up with the SEC last year on a slate of charges that he had cooked up a scheme to make a small amount of money by trading penny stocks using insider information — while lying about not having any interest in the stocks he covered as a senior biotech analyst for Zacks Capital — a federal judge in Chicago has sentenced him to a short, 4-month stretch in prison based on his guilty plea to one count of securities fraud.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.